Conference about The Role of FDA in Health Care Software Regulations and Development
View: 217
Website http://bit.ly/Health_Care_Software |
Edit Freely
Category technology of mobile medicals, medicine apps technology, Managing Software Requirement tools
Deadline: May 02, 2016 | Date: May 03, 2016
Venue/Country: Online Event, U.S.A
Updated: 2016-04-12 18:45:36 (GMT+9)
Call For Papers - CFP
Overview: This presentation will describe the developing area of Health Care Software regulation in the US. It will explain the role of FDA, ONC (Office of the National Coordinator for Health Information Technology), and for wireless apps, the FCC. It will also describe expectations for software that is a device component, as well as standalone software that is a regulated medical deviceWhy should you Attend: Inadequate validation of software continues to be a leading component of device warning letters. Problems mainly include 1) Software that is a component of the manufacturing process (not necessarily a medical device, but like all device class II and III, manufacturing elements, subject to QSR’s), or 2) software that is a component or accessory of some Class III or Class II medical device (Itself a medical device, per FDA guidance). Also, with the proliferation of numerous applications in the Health Care, some developers are still unsure whether or not their product is a medical device. Finally, even though some applications can meet the definition of a medical device, Guidance indicates that FDA is not going to regulate them. Can you tell which is which? Areas Covered in the Session:Who regulates software and whyHow to tell if the software you are developing is a medical deviceWhat does “enforcement discretion” mean and how does it apply to softwareWhat are the expectations for software that’s an integral part of a deviceWhat about software that is offered to analyze signal from a medical device, but is not a part of the device, has a different manufacturer and seller? (e.g., sequencer raw data from manufacturer A, can be analyzed by software from either software seller B or C, and translated using different interfaces from either B or C to the local LIMSWhat about software used in the manufacturing process but not soldWho is enforcing HIPAA, Patient privacy, for device software?And what does Part 11 have to do with my software?Who Will Benefit:Code Developers working on Medical ApplicationsRegulatory Affairs AssociatesHealth Care Software Marketing AssociatesQA associates for firms that are developing/revising Medical SoftwareSpeaker Profile:Anna Longwell is currently principal attorney of the Palo Alto Law firm, Longwell and Associates, which specializes in Food and Drug law. The firm has expertise in US FDA expectations, regulation and law, affecting the development and ultimate marketing of new medical products, drugs, devices and biologics. They have served the regulatory needs of large (>$2 billion/year) divisions of Fortune 500 companies, and small (4 person) biotech start-ups.Contact Detail:Compliance4All DBA NetZealous,Phone: +1-800-447-9407Email: supportcompliance4All.comhttp://www.compliance4all.com/Event Link : http://bit.ly/Health_Care_SoftwareLinkedIn Like us – https://www.linkedin.com/company/compliance4allTwitter Follow us – https://twitter.com/compliance4allFacebook Like us – https://www.facebook.com/Compliance4all
Keywords: Accepted papers list. Acceptance Rate. EI Compendex. Engineering Index. ISTP index. ISI index. Impact Factor.
Disclaimer: ourGlocal is an open academical resource system, which anyone can edit or update. Usually, journal information updated by us, journal managers or others. So the information is old or wrong now. Specially, impact factor is changing every year. Even it was correct when updated, it may have been changed now. So please go to Thomson Reuters to confirm latest value about Journal impact factor.